Citation Impact

Citing Papers

Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3+ T-Regulatory Cells
2012
ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4+ T Cells
2012
Plasmacytoid Dendritic Cells Support Melanoma Progression by Promoting Th2 and Regulatory Immunity through OX40L and ICOSL
2013
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40–Mediated Tumor Rejection
2016 StandoutNobel
Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment
2013
Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer
2013
Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
2013
Impaired IFN-α Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression
2012
Tumoricidal activity of human dendritic cells
2013
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Blood Neutrophil-to-Lymphocyte Ratio is Prognostic in Gastrointestinal Stromal Tumor
2012
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma
2003
Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status
2013
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Safety and Immunogenicity of rSh28GST Antigen in Humans: Phase 1 Randomized Clinical Study of a Vaccine Candidate against Urinary Schistosomiasis
2012
Natural products: A continuing source of novel drug leads
2013 Standout
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Deciphering and Reversing Tumor Immune Suppression
2013
Marine natural products
1990 Standout
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Trabectedin
2007
Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem
2009
Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy
2010
Cancer immunotherapy via dendritic cells
2012 Standout
Evaluation of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin in the Era of Value-Based Medicine
2016
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Vaccine Strategies against Schistosomiasis: From Concepts to Clinical Trials
2001
Colorectal cancer
2019 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Inhibiting eukaryotic transcription. Which compound to choose? How to evaluate its activity?
2011 Standout
Schistosomiasis
2018 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Targeting regulatory T cells
2012
Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review
2020
Rexin-G, a targeted genetic medicine for cancer
2010
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Progress in treatments for colorectal cancer peritoneal metastases during the years 2010–2015. A systematic review
2016
An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma
2014
Summary of current therapeutic options for peritoneal metastases from colorectal cancer
2012
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Natural compounds for cancer treatment and prevention
2009 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Marine natural products
2008
Cancer-related inflammation and treatment effectiveness
2014 Standout
Plasmacytoid dendritic cell in immunity and cancer
2018
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
The immunobiology of schistosomiasis
2002 Standout
Updates on Management of Gastric Cancer
2019
Sinusoidal Injury Increases Morbidity After Major Hepatectomy in Patients With Colorectal Liver Metastases Receiving Preoperative Chemotherapy
2008
Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer
2017
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
2020
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Marine natural products
2015 Standout
Zamamidine C, 3,4-dihydro-6-hydroxy-10,11-epoxymanzamine A, and 3,4-dihydromanzamine J N-oxide, new manzamine alkaloids from sponge Amphimedon sp.
2009 StandoutNobel
Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms
2012
Human dendritic cells in cancer
2022
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
2022 StandoutNobel
Tumor-infiltrating dendritic cell states are conserved across solid human cancers
2020
A Historical Overview of Natural Products in Drug Discovery
2012 Standout
Immunology of Plasmacytoid Dendritic Cells in Solid Tumors: A Brief Review
2019
Dendritic Cell–Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
2015
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Marine Microalgae with Anti-Cancer Properties
2018 Standout
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection.
2016
Alkaloids from Marine Ascidians
2011
Von Hippel-Lindau–Coupled and Transcription-Coupled Nucleotide Excision Repair–Dependent Degradation of RNA Polymerase II in Response to Trabectedin
2008
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute
2016 StandoutNobel

Works of Pierre Méeus being referenced

Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer
2011
Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution
2009
A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region
2010
Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma
2002
Cost-Effectiveness of Intraperitoneal Chemohyperthermia in the Treatment of Peritoneal Carcinomatosis from Colorectal Cancer
2007
Potential of a recombinant Schistosoma bovis-derived glutathione S-transferase to protect cattle against experimental and natural S. mattheei infection
1997
ET-743: a novel agent with activity in soft-tissue sarcomas
2006
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian Cancer.
2015
Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
2008
CYTO-CHIP: Cytoreductive surgery versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: A propensity-score analysis from BIG RENAPE and FREGAT working groups.
2018
A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7.
2018
Rankless by CCL
2026